ReliantHeart (ReliantHeart Inc., Houston, TX, USA) HeartAssist5 (HA5) left ventricular assist device (LVAD) system is a miniaturized, implantable, second- generation axial-flow pump capable of longterm circulatory support in patients with end-stage heart failure. The device results to be the first continuous- flow LVAD ever implanted in human being. This compact axial-flow pump has been in development since 1988 named as MicroMed DeBakey [1] (MicroMed Cardiovascular Inc., Houston, TX, USA) whose design belongs to the second-generation pump category [2, 3].
Antonio, L., Lucio, C., Emanuela, A., Luca, R., Gaetano Domenico Gargiulo, ., Rodger, F. (2017). ReliantHeart: Forward Compatibility and TET. Cham : Springer International Publishing [10.1007/978-3-319-43383-7_54].
ReliantHeart: Forward Compatibility and TET
Lucio CaredduWriting – Original Draft Preparation
;Emanuela AngeliResources
;Luca RagniResources
;Gaetano Domenico GargiuloSupervision
;
2017
Abstract
ReliantHeart (ReliantHeart Inc., Houston, TX, USA) HeartAssist5 (HA5) left ventricular assist device (LVAD) system is a miniaturized, implantable, second- generation axial-flow pump capable of longterm circulatory support in patients with end-stage heart failure. The device results to be the first continuous- flow LVAD ever implanted in human being. This compact axial-flow pump has been in development since 1988 named as MicroMed DeBakey [1] (MicroMed Cardiovascular Inc., Houston, TX, USA) whose design belongs to the second-generation pump category [2, 3].I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
